The individual was drawn to gastrointestinal (GI) tract and hepatobiliary (HPB) cancer following a challenging diagnosis of a rare pancreatic acinar cell carcinoma during their residency at Yale. The mentorship of Juan Rosai and collaborative research at Memorial Sloan Kettering Cancer Center solidified their interest in this area of pathology. Significant advances in understanding the molecular underpinnings of pancreatic and colorectal carcinomas have been made, enhancing diagnosis, treatment, and follow-up. The impact of
1. Encountered rare pancreatic acinar cell carcinoma during residency at Yale2. Mentorship and collaborative research at Memorial Sloan Kettering Cancer Center3. Significant advances in understanding molecular underpinnings of pancreatic and colorectal carcinomas4. Funding challenges for GI and HPB cancers due to rarity5. Importance of early detection of precursor lesions for successful treatment6. Potential game-changers include advanced therapies and biomarkers detection7. Pathology is crucial for understanding tumor biology and genetic alterations8. Research focus on molecular alterations and cancer epidemiology
Listen Tab content
